Over the 2024–2027 planning horizon, Samsung Electronics and its healthcare subsidiaries, including Samsung Medison and Samsung HME America are executing a coordinated transition from traditional medical hardware manufacturing toward a vertically integrated, data driven healthcare ecosystem. This strategic evolution centres on bridging two historically separated sectors: enterprise hospital diagnostic equipment and continuous consumer biometric monitoring.